Dave: let me chime in here man. A large payment to get a stake in Lympro would be better than a sale right now. Honestly, AMBS could get a very large sum of money for a stake in the product or diagnostic spin off in total followed by collection of revenue over time. Best of both worlds really while value is built even more.